[22 January 2014]
Products Affected - Description
Reason for the Shortage
- APP has valproate sodium injection on shortage due to increased demand.
- Ben Venue has stopped production in its plant in Bedford, Ohio and will close in early 2014. Ben Venue supplies multiple sterile injectable products for Bedford Laboratories. Supplies of product that has already been manufactured will continue to be released until inventory is depleted. Bedford Laboratories has a small number of products manufactured elsewhere that are not affected by this closure, but valproate sodium injection is not one of these products.
Valproate injection, APP
100 mg/mL, 5 mL vials (NDC 63323-0494-05)
Valproate injection, Bedford
100 mg/mL, 5 mL vials (NDC 55390-0007-10)
Valproate injection, West-Ward
100 mg/mL, 5 mL vials (NDC 00143-9785-10)
Depacon injection, Abbvie
100 mg/mL, 5 mL vials (NDC 00074-1564-10)
Estimated Resupply Dates
All presentations are currently available.
January 22, 2014; December 4, 2013; October 30, 2013; September 25, 2013; September 16, 2013; August 15, 2013; August 1, 2013; July 23, 2013; June 14, 2013; April 24, 2013; March 20, 2013; January 24, 2013; November 20, 2012; November 14, 2012; September 19, 2012; July 18, 2012; May 22, 2012; March 9, 2012; February 8, 2012; January 4, 2012; November 23, 2011; November 21, 2011; November 15, 2011; November 8, 2011; November 1, 2011; October 4, 2011; August 17, 2011; July 20, 2011; July 1, 2011; June 29, 2011; June 23, 2011; June 7, 2011; April 14, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins